Department of Medical Services Ministry of Public Health of Thailand — Biomedical Watch V2

Traitements6programmes

Essais3liés

Publications0liées

SourceDBlocale

Traitements

6

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Botulinum Toxin type A (Dysport ® ) IM/SC 6-sites pericranial injectionThe purpose of this study is to determine whether 120 Unit, and 240 unit of botulinum toxin A are effective in the treatment of migraine without aura prophylaxis.	Migraine	Phase 3	À vérifier	Thailand	À vérifier
Oligodendrocyte progenitor cell culture/craniotomyRecent developments in the understanding of stem- and progenitor cell differentiation raises hopes that brain damage in chronic neurological diseases may become repaired by systemic or focal transplantation of such cells. Clinical trials of stem- or progenitor cell transplantation in multiple sclerosis are currently premature. The researchers developed a protocol for human oligodendrocyte progenitor cell culture from human brain for the treatment of demyelinating disease.	SEP	Phase 1	Remyélinisation	Thailand	À vérifier
RNASc — Rajavtihi Neuronal Adult Stem Cells ProjectTo study the success of Oligodendrocyte progenitor cell culture project in Rajavithi Hospital to identify an unlimited clone human neuronal progenitor stem cells from the human brain in the Biomolecular Research Center. This study aims to produce the reproductive clone of neuronal development protocols and advance projects. Neuronal cells such as pyramidal cells, oligodendrocyte, and dopaminergic neuron differentiation protocol/projects for treatment of Alzheimer's disease, Multiple sclerosis, and Parkinson's disease respectively in next phase of clinical trials.	SEP	Phase 2	Remyélinisation	Thailand	À vérifier
Botulinum Toxin type A (Dysport ® ) IM/SC 6-sites pericranial injectionThe purpose of this study is to determine whether 120 Unit, and 240 unit of botulinum toxin A are effective in the treatment of migraine without aura prophylaxis.	Migraine	Phase 3	À vérifier	Thailand	À vérifier
RNASc — Rajavtihi Neuronal Adult Stem Cells ProjectTo study the success of Oligodendrocyte progenitor cell culture project in Rajavithi Hospital to identify an unlimited clone human neuronal progenitor stem cells from the human brain in the Biomolecular Research Center. This study aims to produce the reproductive clone of neuronal development protocols and advance projects. Neuronal cells such as pyramidal cells, oligodendrocyte, and dopaminergic neuron differentiation protocol/projects for treatment of Alzheimer's disease, Multiple sclerosis, and Parkinson's disease respectively in next phase of clinical trials.	SEP	Phase 2	Remyélinisation	Thailand	À vérifier
Oligodendrocyte progenitor cell culture/craniotomyRecent developments in the understanding of stem- and progenitor cell differentiation raises hopes that brain damage in chronic neurological diseases may become repaired by systemic or focal transplantation of such cells. Clinical trials of stem- or progenitor cell transplantation in multiple sclerosis are currently premature. The researchers developed a protocol for human oligodendrocyte progenitor cell culture from human brain for the treatment of demyelinating disease.	SEP	Phase 1	Remyélinisation	Thailand	À vérifier

Essais cliniques

3

Molécule	Indication / population	Phase	NCT	Titre	Statut
Oligodendrocyte progenitor cell culture/craniotomy	SEP	Phase 1	NCT00283023	Oligodendrocyte Progenitor Cell Culture From Human Brain	COMPLETED
RNASc — Rajavtihi Neuronal Adult Stem Cells Project	SEP	Phase 2	NCT00927108	RNASc — Rajavtihi Neuronal Adult Stem Cells Project	WITHDRAWN
Botulinum Toxin type A (Dysport ® ) IM/SC 6-sites pericranial injection	Migraine	Phase 3	NCT00258609	Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study	COMPLETED

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.